Targeting GABA_B receptors for anti-abuse drug discovery

Bibliography

• Yahn SL, Watterson LR, Olive MF. Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abuse 2013;6:1-12
   PubMedGoogle Scholar
• Brogden RN, Speight TM, Avery GS. Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 1974;8(1):1-14
   PubMed Web of Science ®Google Scholar
• Benke D, Zemoura K, Maier PJ. Modulation of cell surface GABAB receptors by desensitization, trafficking and regulated degradation. World J Biol Chem 2012;3(4):61-72
   PubMedGoogle Scholar
• Kumar K, Sharma S, Kumar P, Deshmukh R. Therapeutic potential of GABAB receptor ligands in drug addiction, anxiety, depression and other CNS disorders. Pharmacol Biochem Behav 2013;110:174-84
   PubMed Web of Science ®Google Scholar
• Filip M, Frankowska M, Sadakierska-Chudy A, et al. GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators. Neuropharmacology 2014. Published online 24 June 2014;https://doi.org/10.1016/j.neuropharm.2014.06.016 doi:10.1016/j.neuropharm.2014.06.016
   Google Scholar
• Pin JP, Prézeau L. Allosteric modulators of GABAB receptors: mechanism of action and therapeutic perspective. Curr Neuropharmacol 2007;5(3):195-201
   PubMed Web of Science ®Google Scholar
• Koek W, Cheng K, Rice KC. Discriminative stimulus effects of the GABAB receptor-positive modulator rec-BHFF: comparison with GABAB receptor agonists and drugs of abuse. J Pharmacol Exp Ther 2013;344(3):553-60
   PubMed Web of Science ®Google Scholar
• Urwyler S, Gjoni T, Koljatic J, Dupuis DS. Mechanisms of allosteric modulation of GABAB receptors by CGP7930 and GS39783: effects and affinities of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 2005;48(3):343-53
   PubMed Web of Science ®Google Scholar
• Cryan JF, Kelly PH, Chaperon F, et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N’-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 2004;310(3):952-63
   PubMed Web of Science ®Google Scholar
• Beveridge TJ, Smith HR, Porrino LJ. Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats. Pharmacol Biochem Behav 2013;106:27-32
   PubMed Web of Science ®Google Scholar
• Benarroch EE. GABAB receptors: structure, functions, and clinical implications. Neurology 2012;78(8):578-84
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;1335(1):217-23
   Google Scholar
• Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007;30:259-88
   PubMed Web of Science ®Google Scholar
• Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987;94(4):469-92
   PubMed Web of Science ®Google Scholar
• Bowery NG, Hudson AL, Price GW. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 1987;20(2):365-83
   PubMed Web of Science ®Google Scholar
• Xi ZX, Stein EA. GABAergic mechanisms of opiate reinforcement. Alcohol Alcohol 2002;37(5):485-94
   PubMed Web of Science ®Google Scholar
• Doherty M, Gratton A. Differential involvement of ventral tegmental GABAA and GABAB receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res 2007;1150:62-8
   PubMed Web of Science ®Google Scholar
• Walaas I, Fonnum F. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions. Brain Res 1979;177(2):325-36
   PubMed Web of Science ®Google Scholar
• Engberg G, Kling-Peterson T, Nissbrandt H. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Synapse 1993;15(3):229-38
   PubMed Web of Science ®Google Scholar
• Kalivas P. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 1993;18(1):75-113
   PubMed Web of Science ®Google Scholar
• Giorgetti M, Hotsenpiller G, Froestl W, Wolf ME. In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABAB receptors is altered after repeated amphetamine treatment. Neuroscience 2002;109(3):585-95
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005;8(11):1445-9
   PubMed Web of Science ®Google Scholar
• Wirtshafter D, Shepard AC. Localization of GABAB receptors in midbrain monoamine containing neurons in the rat. Brain Res Bull 2001;56(1):1-5
   PubMed Web of Science ®Google Scholar
• Everitt BJ, Belin D, Economidou D. Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 2008;363(1507):3125-35
   PubMed Web of Science ®Google Scholar
• Yin HH, Ostlund SB, Knowlton BJ, Balleine BW. The role of the dorsomedial striatum in instrumental conditioning. Eur J Neurosci 2005;22(2):513-23
   PubMed Web of Science ®Google Scholar
• Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 1998;101(6):1045-8
   PubMed Web of Science ®Google Scholar
• Weiβhaar GF, Hoemberg M, Bender K, et al. Baclofen intoxication: a “fun drug” causing deep coma and nonconvulsive status epilepticus- a case report and review of the literature. Eur J Pediatr 2012;171(10):1541-7
   PubMed Web of Science ®Google Scholar
• Faigle JW, Keberle H. The chemistry and kinetics of Lioresal. Postgrad Med J 1972;48(Suppl 5):9-13
   PubMedGoogle Scholar
• Agabio R, Maccioni P, Carai MAM, et al. The development of medication for alcohol-use disorders targeting the GABAB receptor system. Recent Pat CNS Drug Discov 2012;7(2):113-28
   PubMedGoogle Scholar
• Froestl W. Chemistry and pharmacology of GABAB receptor ligands. Adv Pharmacol 2010;58:19-62
   PubMedGoogle Scholar
• Han C, Salyer AE, Kim EH, et al. Evaluation of difluoromethyl ketones as agonists of the γ-aminobutyric acid type B (GABAB) receptor. J Med Chem 2013;56(6):2456-65
   PubMed Web of Science ®Google Scholar
• Roberts DCS. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol Behav 2005;86(1-2):18-20
   PubMed Web of Science ®Google Scholar
• Leggio L, Garbutt JC, Addolorato G. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Disord Drug Targets 2010;9(1):33-44
   PubMed Web of Science ®Google Scholar
• Gorsane MA, Kebir O, Hache G, et al. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abus 2012;33(4):336-49
   PubMed Web of Science ®Google Scholar
• Liu J, Wang LN. Baclofen for alcohol withdrawal. Cochrane Database Syst Rev 2013;2:CD008502
   PubMedGoogle Scholar
• Agabio R, Colombo G. GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 2014;8:140
   PubMed Web of Science ®Google Scholar
• Cousins MS, Roberts DCS, deWit H. GABAB receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 2002;65(3):209-20
   PubMed Web of Science ®Google Scholar
• Bowery NG. GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol 2006;6(1):37-43
   PubMed Web of Science ®Google Scholar
• Adams CL, Lawrence AJ. CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev 2007;13(3):308-16
   PubMedGoogle Scholar
• Tyacke RJ, Lingford-Hughes A, Reed LJ, Nutt DJ. GABAB receptors in addiction and its treatment. Adv Pharmacol 2010;58:373-96
   PubMedGoogle Scholar
• Vlachou S, Markou A. GABAB receptors in reward processes. Adv Pharmacol 2010;58:315-71
   PubMedGoogle Scholar
• Yahyavi-Firouz-Abadi N, See RE. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther 2009;124(2):235-47
   PubMed Web of Science ®Google Scholar
• Napier TC, Herrold AA, deWit H. Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev 2013;37(9 Pt A):2081-6
   PubMed Web of Science ®Google Scholar
• Pastor A, Jones DM, Currie J. High-dose baclofen for treatment-resistant alcohol dependence. J Clin Psychopharmacol 2012;32(2):266-8
   PubMed Web of Science ®Google Scholar
• Chick J, Nutt DJ. Substitution therapy for alcoholism: time for a reappraisal? J Psychopharmacol 2012;26(2):205-12
   PubMed Web of Science ®Google Scholar
• Rolland B, Bordet R, Deheul S, Cottencin O. Baclofen for alcohol-dependence: anticraving or partial substitution? J Clin Psychoharmacol 2013;33(2):280-1
   PubMed Web of Science ®Google Scholar
• Pastor A, Lloyd-Jones M, Currie J. Reply to Dr Rolland et al. re: “Baclofen for alcohol-dependence: anticraving or partial substitution?”. J Clin Psychoharmacol 2013;33(2):281-2
   PubMed Web of Science ®Google Scholar
• Boehm SL II, Piercy MM, Bergstrom HC, Phillips TJ. Ventral tegmental area region governs GABAB receptor modulation of ethanol-stimulated activity in mice. Neuroscience 2002;115(1):185-200
   PubMed Web of Science ®Google Scholar
• Moore EM, Boehm SL II. Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in make C57BL/6J mice. Behav Neurosci 2009;123(3):555-63
   PubMed Web of Science ®Google Scholar
• Méndez-Díaz M, Caynas Rojas S, Gómez Armas D, et al. Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats. Brain Res Bull 2013;91:31-7
   PubMed Web of Science ®Google Scholar
• Maccioni P, Zaru A, Loi B, et al. Comparison of the effects of the GABAB receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. Alcohol Clin Exp Res 2012;36(10):1748-66
   PubMed Web of Science ®Google Scholar
• Hwa LS, Kalinichev M, Haddouk H, et al. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology (Berl) 2014;231(2):333-43
   PubMed Web of Science ®Google Scholar
• Besheer J, Lepoutre V, Hodge CW. GABAB receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology (Berl) 2004;174(3):358-66
   PubMed Web of Science ®Google Scholar
• Holstein SE, Dobbs L, Phillips TJ. Attenuation of the stimulant response to ethanol is associated with enhanced ataxia for a GABAA, but not a GABAB, receptor agonist. Alcohol Clin Exp Res 2009;33(1):108-20
   PubMed Web of Science ®Google Scholar
• Holstein SE, Li N, Eshleman AJ, Phillips TJ. GABAB receptor activation attenuates the stimulant but not mesolimbic dopamine response to ethanol in FAST mice. Behav Brain Res 2013;237:49-58
   PubMed Web of Science ®Google Scholar
• Robinson TE, Berridge KC. The neural basis of drug craving: an incentive sensitization theory of addiction. Brain Res Rev 1993;18(3):247-91
   PubMed Web of Science ®Google Scholar
• Pastor R, Kamens HM, McKinnon CS, et al. Repeated ethanol administration modifies the temporal structure of sucrose intake patterns in mice: effects associated with behavioral sensitization. Addict Biol 2010;15(3):324-35
   PubMed Web of Science ®Google Scholar
• Rolland B, Paille F, Fleury B, et al. Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey. PLoS One 2014;9(6):e98062
   PubMed Web of Science ®Google Scholar
• Enoch MA, Zhou Z, Kimura M, et al. GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. PLoS One 2012;7(1):e29369
   PubMed Web of Science ®Google Scholar
• Lee C, Mayfield RD, Harris RA. Altered gamma-aminobutyric acid type B receptor subunit 1 splicing in alcoholics. Biol Psychiatry 2014;75:765-73
   PubMed Web of Science ®Google Scholar
• Connelly WM, Fyson SJ, Errington AC, et al. GABAB receptors regulate extrasynaptic GABAA receptors. J Neurosci 2013;33(9):3780-5
   PubMed Web of Science ®Google Scholar
• Tao W, Higgs MH, Spain WJ, Ransom CB. Postsynaptic GABAB receptors enhance extrasynaptic GABAA receptor function in dentate gyrus granule cells. J Neurosci 2013;33(9):3738-43
   PubMed Web of Science ®Google Scholar
• Caine SB, Koob GF. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 1994;270(1):209-18
   PubMed Web of Science ®Google Scholar
• Backes EN, Hemby SE. Contribution of ventral tegmental GABA receptors to cocaine self-administration in rats. Neurochem Res 2008;33(3):459-67
   PubMed Web of Science ®Google Scholar
• Filip M, Frankowska M, Przegaliński E. Effects of GABAB receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 2007;574(2-3):148-57
   PubMed Web of Science ®Google Scholar
• Holtz NA, Carroll ME. Baclofen has opposite effects on escalation of cocaine self-administration: increased intake in rats selectively bred for high (HiS) saccharin intake and decreased intake in those selected for low (LoS) saccharin intake. Pharmacol Biochem Behav 2011;100(2):275-83
   PubMed Web of Science ®Google Scholar
• Weerts EM, Froestl W, Kaminski BJ, Griffiths RR. Attenuation of cocaine-seeking by GABAB receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend 2007;89(2-3):206-13
   PubMed Web of Science ®Google Scholar
• Halbout B, Quarta D, Valerio E, et al. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward. Addict Biol 2011;16(3):416-27
   PubMed Web of Science ®Google Scholar
• Porrino LJ, Hampson RE, Opris I, Deadwyler SA. Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen. Psychopharmacology (Berl) 2013;225(1):105-14
   PubMed Web of Science ®Google Scholar
• Steketee JD, Beyer CE. Injections of baclofen into the ventral medial prefrontal cortex block the initiation, but not the expression, of cocaine sensitization in rats. Psychopharmacology (Berl) 2005;180(2):352-8
   PubMed Web of Science ®Google Scholar
• Frankowska M, Nowak E, Filip M. Effects of GABAB receptor agonists on cocaine hyperlocomotor and sensitizing effects in rats. Pharmacol Rep 2009;61(6):1042-9
   PubMed Web of Science ®Google Scholar
• Kahn R, Biswas K, Childress AR, et al. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend 2009;103(1-2):59-64
   PubMed Web of Science ®Google Scholar
• Young KA, Franklin TR, Roberts DC, et al. Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci 2014;34(14):5038-43
   PubMed Web of Science ®Google Scholar
• Ramshini E, Alaei H, Reisi P, et al. The role of GABAB receptors in morphine self-administration. Int J Prev Med 2013;4(2):158-64
   PubMedGoogle Scholar
• Kaplan GB, Leite-Morris KA, Joshi M, et al. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res 2003;987(1):122-5
   PubMed Web of Science ®Google Scholar
• Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB. Baclofen enhances extinction of opiate conditioned place preference. Behav Brain Res 2010;207(2):353-9
   PubMed Web of Science ®Google Scholar
• Zarrindast MR, Massoudi R, Sephri H, Rezayof A. Involvement of GABAB receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol Behav 2006;87(1):31-8
   PubMed Web of Science ®Google Scholar
• Sahraei H, Etemadi L, Rostami P, et al. GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacol Biochem Behav 2009;91(3):409-16
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Ricci F, Gaiardi M. A GABA(B) agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology (Berl) 2007;192(1):79-85
   PubMed Web of Science ®Google Scholar
• Fu Z, Yang H, Xiao Y, et al. The gamma-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in the rat nucleus accumbens. Behav Brain Funct 2012;8-20
   PubMed Web of Science ®Google Scholar
• Leite-Morris KW, Fukudome EY, Shoeb MH, Kaplan GB. GABAB receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. J Pharmacol Exp Ther 2004;308(2):667-78
   PubMed Web of Science ®Google Scholar
• Riahi E, Mirzaii-Dizgah I, Karimian SM, et al. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats. Behav Brain Res 2009;196:11-14
   PubMed Web of Science ®Google Scholar
• Zarrindast MR, Highooghi V, Rezayof A. Inhibition of morphine-induced amnesia in morphine-sensitized mice: involvement of dorsal hippocampal GABAergic receptors. Neuropharmacology 2008;54(1):569-76
   PubMedGoogle Scholar
• Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, et al. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized control trial. J Clin Pharm Ther 2001;26(1):67-71
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Ahmadi-Abhari SA, Assadi SM, et al. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal. J Clin Pharm Ther 2000;25(5):347-53
   PubMed Web of Science ®Google Scholar
• Assadi SM, Radgoodarzi R, Ahmadi-Abhari SA. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]. BMC Psychiatry 2003;3:16
   PubMed Web of Science ®Google Scholar
• Kenna GA, Nielsen DM, Mello P, et al. Pharmacotherapy of dual substance abuse and dependence. CNS Drugs 2007;21(3):213-37
   PubMed Web of Science ®Google Scholar
• Lobina C, Carai MAM, Froestl W, et al. Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice. Front Psychiatry 2011;2:76
   PubMedGoogle Scholar
• Varani AP, Aso E, Moutinho LM, et al. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology (Berl) 2014;231(15):3031-40
   PubMed Web of Science ®Google Scholar
• Vlachou S, Paterson NE, Guery S, et al. Both GABAB activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats. Eur J Pharmacol 2011;655(1-3):52-8
   PubMed Web of Science ®Google Scholar
• Cousins MS, Stamat HM, deWit H. Effect of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob Res 2001;3(2):123-9
   PubMedGoogle Scholar
• Franklin TR, Harper D, Kampman K, et al. The GABA B agonist baclofen reduces cigarette consumption in a preliminary double blind placebo-controlled smoking reduction study. Drug Alcohol Depend 2009;103(1-2):30-6
   PubMed Web of Science ®Google Scholar
• Franklin TR, Shin J, Jagannathan K, et al. Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study. Drug Alcohol Depend 2012;125(1-2):60-6
   PubMed Web of Science ®Google Scholar
• Padgett CL, Lalive AL, Tan KR, et al. Methamphetamine-evoked depression of GABAB receptor signaling in GABA neurons of the VTA. Neuron 2012;73(5):978-89
   PubMed Web of Science ®Google Scholar
• Phillis BD, Ong J, White MJ, Bonnielle C. Modification of d-amphetamine-induced responses by baclofen in rats. Psychopharmacology (Berl) 2001;153(3):277-84
   PubMed Web of Science ®Google Scholar
• Zhou W, Mailloux AW, Jung BJ, et al. GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Brain Res 2004;1004(1-2):18-28
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Gubellini C, Ricci F, Gaiardi M. The GABAB agonist baclofen blocks the expression of sensitization to the locomotor stimulant effects of amphetamine. Behav Pharmacol 2004;15(5-6):397-401
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Gubellini C, Ricci F, Gaiardi M. Baclofen blocks the development of sensitization to the locomotor stimulant effects of amphetamine. Behav Pharmacol 2005;16(7):553-8
   PubMed Web of Science ®Google Scholar
• Cedillo LN, Miranda F. Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats. Pharmacol Rep 2013;65(5):1132-43
   PubMed Web of Science ®Google Scholar
• Voigt RM, Herrold AA, Napier TC. Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats. Behav Neurosci 2011;125(2):261-7
   PubMed Web of Science ®Google Scholar
• Voigt RM, Herrold AA, Riddle JL, Napier TC. Administration of GABAB receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behav Brain Res 2011;216(1):419-23
   PubMed Web of Science ®Google Scholar
• Ranaldi R, Poeggel K. Baclofen decreases methamphetamine self-administration in rats. Neuroreport 2002;13(9):1107-10
   PubMed Web of Science ®Google Scholar
• Brebner K, Ahn S, Phillips AG. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl) 2005;177(4):409-17
   PubMed Web of Science ®Google Scholar
• Arai S, Takuma K, Mizoguchi H, et al. GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice. Eur J Pharmacol 2009;602(1):101-4
   PubMed Web of Science ®Google Scholar
• Mizoguchi H, Yamada K. Pharmacological treatment with GABAB receptor agonist of methamphetamine-induced cognitive impairment in mice. Curr Neuropharm 2011;9(1):109-12
   PubMed Web of Science ®Google Scholar
• Brackins T, Brahm NC, Kissack JC. Treatments for methamphetamine abuse a literature review for the clinician. J Pharm Pract 2011;24(6):541-50
   PubMedGoogle Scholar
• Heinzerling KG, Shoptaw S, Peck JA, et al. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006;85(3):177-84
   PubMed Web of Science ®Google Scholar
• Garbutt JC, Greenblatt AM, West SL, et al. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction 2014;109(8):1274-84
   PubMed Web of Science ®Google Scholar
• Miner P, Borkuhova Y, Shimonova L, et al. GABA-A and GABA-B receptors mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions. Brain Res 2010;1355:86-96
   PubMed Web of Science ®Google Scholar
• Gjoni T, Urwyler S. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization. Neuropharmacology 2008;55(8):1293-9
   PubMed Web of Science ®Google Scholar